. 2022 Jan 29;29(28):43114–43125. doi: 10.1007/s11356-021-18331-3

Table 3.

Rat’s sperm count and motility after 1 and 2 months of treatment by AC and AZ doses

Semen evaluation		Acetamiprid doses			Azoxystrobin doses			Control
Sperm	Duration	1/10 LD₅₀	1/20 LD₅₀	1/40 LD₅₀	1/10 LD₅₀	1/20 LD₅₀	1/40 LD₅₀
Count (million/mL)	1^st month	84 ± 1.15^a	90.33 ± 0.88 ^a,b	96.67 ± 0.88 ^a,b	93.33 ± 0.88 ^a	98 ± 1.15 ^a,b	101.67 ± 1.45 ^a,b	110.67 ± 1.76
Count (million/mL)	2^nd month	87.33 ± 0.67 ^a	93.67 ± 0.88 ^a,b	98.33 ± 1.20 ^a,b	91 ± 1.0 ^a	99 ± 0.58 ^a,b	106 ± 1.15 ^a,b	120 ± 1.15
Motility (%)	1^st month	73.33 ± 0.88 ^a	76.33 ± 0.88 ^a,b	79 ± 0.58 ^a,b	80.67 ± 0.67 ^a	87 ± 1.0 ^a,b	92.33 ± 0.88 ^a,b	90.33 ± 0.88
Motility (%)	2^nd month	68 ± 1.15 ^a	73 ± 1.73 ^a,b	78.67 ± 0.88 ^a,b	76 ± 1.15 ^a	82.33 ± 1.45 ^a,b	87.67 ± 1.20 ^a,b	90.67 ± 1.20

Data presented as mean ± S.E. ^a significant difference (1/10, 1/20, 1/40) LD₅₀ as compared to the control group, ^b significant difference as compared to the 1/10 LD₅₀ group (n = 8/group; n = 4 at each time)